Gastric Ulcer
📧 Sign up to get email alerts when something new happens for Gastric Ulcer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-07-15FDA Approved: EQUATE OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (WALMART INC.)
FDA approved the original ANDA for Equate Omeprazole and Sodium Bicarbonate (Walmart Inc.), a store-brand combination proton pump inhibitor …
-
FDA approval · 2016-06-07FDA Approved: EQUATE LANSOPRAZOLE — Original Application (Wal-Mart Stores Inc)
FDA approves Equate Lansoprazole (Wal-Mart Stores Inc) under an Original Application for lansoprazole.
-
FDA approval · 2016-06-06FDA Approved: CARAFATE — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for CARAFATE (sucralfate) submitted by Allergan, Inc.
-
FDA approval · 2016-06-01FDA Approved: LANSOPRAZOLE — Original Application (Rite Aid Corporation)
FDA approved an original-application generic lansoprazole (a proton pump inhibitor) as an approved product; Rite Aid Corporation was the app…
-
FDA approval · 2016-05-05FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Pepcid AC Maximum Strength (famotidine) submitted by Kenvue Brands LLC. The approval pertains to…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-04-21FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for esomeprazole magnesium from Aurobindo Pharma Limited, making a generic version of this proton pump…
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Clinical Trial Evaluating Gastrointestinal Damage Following Administration PL3100 or Naproxen in At-Risk Adults [Phase 2]
A Phase 2 trial evaluated gastrointestinal damage after administration of PL3100 versus naproxen in at-risk adults; results have been posted…
-
FDA approval · 2016-03-30FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Eugia US LLC)
The FDA approved Pantoprazole sodium from Eugia US LLC under an original ANDA, making a generic pantoprazole product available. It is indica…
-
FDA approval · 2016-03-18FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (XLCare Pharmaceuticals Inc.)
FDA approved a supplemental application for Pantoprazole Sodium from XLCare Pharmaceuticals Inc., approving a change to this generic product…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Pharmacodynamics and Safety of CDFR0209 [Phase 1]
Phase 1 trial update reporting pharmacodynamics and safety data for CDFR0209 in gastric ulcer and gastroesophageal reflux disease; study com…
-
FDA approval · 2016-02-25FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for omeprazole from Lannett Company, Inc., effectively updating the product labeling under the ANDA.
-
CLINICAL_TRIALS research · 2016-02-24Clinical Trial Update: A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection [NA]
A multi-center clinical trial is studying individualized treatment for Helicobacter pylori infection, with gastritis and gastric ulcer as co…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]
Completed clinical trial update evaluating intravenous lansoprazole 30 mg for hemostatic effects and rebleeding rates in gastric and duodena…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers [Phase 3]
Phase 3 study evaluating incidence of gastric ulcers with PA32540 (aspirin + omeprazole) versus enteric-coated aspirin 325 mg in at-risk ind…
-
FDA approval · 2016-02-10FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application to authorize Good Neighbor Pharmacy Omeprazole (omeprazole) as a store-brand proton pump inhibitor m…
-
FDA approval · 2016-02-03FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) submitted by Covis Pharma US, Inc. The approval pertains to a mo…
-
FDA approval · 2016-01-26FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' original application for pantoprazole sodium, a generic pantoprazole product, expanding access to a pro…
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers [Phase 3]
A Phase 3 trial comparing PA32540 (aspirin with omeprazole) to enteric-coated aspirin 325 mg to evaluate the incidence of gastric ulcers in …
-
FDA approval · 2015-12-22FDA Approved: FAMOTIDINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for famotidine from Aurobindo Pharma Limited, enabling a generic version of famotidine to be marketed.
-
FDA approval · 2015-12-16FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application to add PREVACID SOLUTAB (lansoprazole) as a soluble tablet formulation. This expands the approve…
-
FDA approval · 2015-12-16FDA Approved: PREVACID — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for PREVACID (lansoprazole) submitted by Takeda Pharmaceuticals America, Inc. The approval updates t…
-
CLINICAL_TRIALS trial_result · 2015-11-16Clinical Trial Update: Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study) [Phase 2, Phase 3]
The Planetarium Study, a Phase 2/3 trial, reports completed results on using rabeprazole to prevent recurrence of aspirin-induced gastric an…
-
FDA approval · 2015-10-30FDA Approved: SUCRALFATE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for sucralfate from Chartwell RX, LLC under an ANDA. The action represents an update to the approved…
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs
A completed Takeda trial evaluated long-term Takepron for preventing recurrence of NSAID-associated gastric or duodenal ulcers; results were…
-
FDA approval · 2015-09-25FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (NorthStar Rx LLC)
FDA approved the original application for esomeprazole magnesium from NorthStar Rx LLC, a generic version of the proton pump inhibitor esome…